Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 7, 2011, Pages 1590-1593

  Bejon, Philip ^a,b   Byren, Ivor ^a   Atkins, Bridget L ^a,c   Scarborough, Matthew ^a   Woodhouse, Andrew ^a   McLardy Smith, Peter ^a   Gundle, Roger ^a   Berendt, Anthony R ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Biomarker; Debridement and retention; Sensitivity; Specificity; Two stage revision

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; DEBRIDEMENT; FEMALE; HIP ARTHROPLASTY; HUMAN; JOINT PROSTHESIS; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTHESIS INFECTION; PROTEIN ANALYSIS; REOPERATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

C-REACTIVE PROTEIN; DRUG MONITORING; HUMANS; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 79958832741     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr182     Document Type: Article

References (10)

1. HPA. Fourth Report of the Mandatory Surveillance of Surgical Site Infection in Orthopaedic Surgery. April 2004 to March 2008. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1227774003450 (12 April 2011, date last accessed).
2. Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31: 99-108.
3. Atkins BL, Athanasou N, Deeks JJ et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 1998; 36: 2932-9.
4. Berbari E, Mabry T, Tsaras G et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J one Joint Surg Am 2010; 92: 2102-9.
5. Ghanem E, Azzam K, Seeley M et al. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop elat Res 2009; 467: 1699-705.
6. Kusuma SK, Ward J, Jacofsky M et al. What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? lin Orthop Relat Res 2010; 469: 1002-8.
7. Shukla SK, Ward JP, Jacofsky MC et al. Perioperative testing for persistent sepsis following resection arthroplasty of the hip for periprosthetic infection. J rthroplasty 2010; 25: 87-91.
8. Bejon P, Berendt A, Atkins BL et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J ntimicrob Chemother 2010; 65: 569-75.
9. Byren I, Bejon P, Atkins BL et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63: 1264-71.
10. Verhagen DW, Hermanides J, Korevaar JC et al. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch ntern Med 2008; 168: 302-7.